Literature DB >> 19225348

Glaucoma in Africa: size of the problem and possible solutions.

Colin Cook1.   

Abstract

PURPOSE: To obtain an estimate of the magnitude of the problem of glaucoma in sub-Saharan Africa, and to evaluate the existing evidence for including glaucoma as a priority disease in our Vision 2020 programs in Africa.
METHODS: A Pubmed search was carried out using "glaucoma prevalence Africa," "glaucoma presentation Africa," "glaucoma blindness Africa," "glaucoma screening Africa," and "glaucoma treatment Africa" as key words.
RESULTS: Most glaucoma in Africa is primary chronic open angle glaucoma, it may occur at an earlier age, it may be associated with a higher intraocular pressure, it may be more rapidly progressive, and it may present late. The prevalence of glaucoma in East, Central, and Southern Africa can be conservatively estimated to be 10,000 people for every 1 million population. This prevalence may be higher in West Africa. The annual incidence of glaucoma can be conservatively estimated to be 400 new cases for every 1 million population. Glaucoma is the second leading cause of blindness after cataract, responsible for up to 30% of blindness. Case detection of glaucoma could be carried out at both the primary and secondary level. Primary trabeculectomy with mitomycin C or beta irradiation adjunct may be a suitable treatment. Cases could be followed up after surgery by mid-level eye care workers, using the intraocular pressure as the indicator for adequacy of control, and using a glaucoma register to identify and trace defaulters.
CONCLUSIONS: Glaucoma should be included as a priority disease in Vision 2020 programs in Africa.

Entities:  

Mesh:

Year:  2009        PMID: 19225348     DOI: 10.1097/IJG.0b013e318189158c

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  32 in total

1.  South African Eye Study (SAES): ethnic differences in central corneal thickness and intraocular pressure.

Authors:  S O Baboolal; D P Smit
Journal:  Eye (Lond)       Date:  2018-01-12       Impact factor: 3.775

2.  Severity of Visual Field Loss at First Presentation to Glaucoma Clinics in England and Tanzania.

Authors:  Pete R Jones; Heiko Philippin; William U Makupa; Matthew J Burton; David P Crabb
Journal:  Ophthalmic Epidemiol       Date:  2019-09-13       Impact factor: 1.648

3.  Presentation of Primary Open Angle Glaucoma (POAG) at Lions Sight First Eye Hospital in Blantyre, Malawi.

Authors:  P C Kayange; H B Nkume; A Feyi-Waboso; K Kalua; G Msukwa; M Schwering Schulze
Journal:  Malawi Med J       Date:  2014-09       Impact factor: 0.875

4.  Glaucoma awareness among people attending ophthalmic outreach services in Southwestern Ethiopia.

Authors:  Addis Tenkir; Berhan Solomon; Amare Deribew
Journal:  BMC Ophthalmol       Date:  2010-05-28       Impact factor: 2.209

5.  The East London glaucoma prediction score: web-based validation of glaucoma risk screening tool.

Authors:  Cook Stephen; Longo-Mbenza Benjamin
Journal:  Int J Ophthalmol       Date:  2013-02-18       Impact factor: 1.779

Review 6.  Glaucoma drainage implant surgery--an evidence-based update with relevance to sub-Saharan Africa.

Authors:  Ardalan E Aminlari; Ingrid U Scott; Ahmad A Aref
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Apr-Jun

Review 7.  Epidemiology of glaucoma in sub-saharan Africa: prevalence, incidence and risk factors.

Authors:  Fatima Kyari; Mohammed M Abdull; Andrew Bastawrous; Clare E Gilbert; Hannah Faal
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Apr-Jun

8.  Is glaucoma blindness a disease of deprivation and ignorance? A case-control study for late presentation of glaucoma in India.

Authors:  Parikshit Gogate; Roma Deshpande; Vidya Chelerkar; Swapna Deshpande; Madan Deshpande
Journal:  Indian J Ophthalmol       Date:  2011 Jan-Feb       Impact factor: 1.848

9.  Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya.

Authors:  Andrew Bastawrous; Wanjiku Mathenge; John Buchan; Fatima Kyari; Tunde Peto; Hillary Rono; Helen A Weiss; David Macleod; Allen Foster; Matthew J Burton; Hannah Kuper
Journal:  J Glaucoma       Date:  2018-05       Impact factor: 2.503

10.  Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana.

Authors:  Charles Nii Kwade Ofei-Palm; Naa Naamuah Tagoe; Dong Jatoe; Angela Agyare; Daniel Ankrah
Journal:  Clinicoecon Outcomes Res       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.